Search our Innovation Portfolio

DemDx guides the clinician through a decision making process as they ask the patient questions. Depending on the responses, users are suggested the best next step to take based on the latest national and local clinical guidance. Simultaneously the software generates comprehensive and concise clinical notes. The product is run on a proprietary database developed with 200+ specialists, representing millions of hours of clinical experience. The database contains more than 2 million fully audited pathways leading to more than 2,800 diagnoses and has full International Copyright protection.

Safe Steps is a digital falls prevention tool that uses real-time monitoring and data-driven insights to assess and track fall risks. It provides care teams with proactive alerts, enabling timely interventions to reduce falls. By continuously evaluating patient data, Safe Steps enhances risk management, improves safety, and reduces hospital admissions, making it an essential tool for care organisations. This scalable technology supports improved patient outcomes and alleviates pressure on healthcare resources.

MeMed BV® is the first FDA-cleared and CE-Marked host-immune response assay for accurately distinguishing bacterial and viral infections in just 15 minutes in children and adults.
MeMed BV’s performance has been validated in multi-national, blinded clinical studies and real world settings enrolling >20,000 subjects in Europe, Israel and the United States. These studies consistently demonstrated high performance across settings, ages, and syndromes.
MeMed Key® is a compact platform that runs highly sensitive protein measurements that previously could only be done on large, expensive lab equipment. Together, MeMed Key and BV help physicians make better decisions when managing acute infections.